Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Amlodipine, Losartan, and Chlorthalidone in Healthy Volunteers
NCT02387554Phase 1Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine, losartan and chlorthalidone in hypertension (HTN) (4 arms), sponsored by Hanmi Pharmaceutical. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration and Maximum Plasma Concentration. Started Aug 2014; status: completed.
02
Drugs
amlodipinelosartanchlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02387554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387554.